Peter Moldt - Net Worth and Insider Trading

Peter Moldt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Moldt owns 3 companies in total, including Aligos Therapeutics Inc (ALGS) , Corvus Pharmaceuticals Inc (CRVS) , and Bolt Biotherapeutics Inc (BOLT) .

Click here to see the complete history of Peter Moldt’s form 4 insider trades.

Insider Ownership Summary of Peter Moldt

Ticker	Company	Transaction Date	Type of Owner
ALGS	Aligos Therapeutics Inc	2020-10-15	director
CRVS	Corvus Pharmaceuticals Inc	2016-03-22	director
BOLT	Bolt Biotherapeutics Inc	2021-02-04	director

Peter Moldt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter Moldt Ownership Network

Ownership Network List of Peter Moldt

No Data

Ownership Network Relation of Peter Moldt

Peter Moldt Owned Company Details

What does Aligos Therapeutics Inc do?

Who are the key executives at Aligos Therapeutics Inc?

Peter Moldt is the director of Aligos Therapeutics Inc. Other key executives at Aligos Therapeutics Inc include 10 percent owner Roche Holding Ltd , 10 percent owner Roche Finance Ltd , and Chief Medical Officer Matthew W. Mcclure .

Aligos Therapeutics Inc (ALGS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aligos Therapeutics Inc (ALGS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aligos Therapeutics Inc (ALGS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aligos Therapeutics Inc (ALGS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aligos Therapeutics Inc Insider Transactions

No Available Data

What does Corvus Pharmaceuticals Inc do?

Who are the key executives at Corvus Pharmaceuticals Inc?

Peter Moldt is the director of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , See Remarks William Benton Jones , and Chief Financial Officer Leiv Lea .

Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary

Over the past 18 months, Peter Moldt made no insider transaction in Corvus Pharmaceuticals Inc (CRVS). Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 577,634 shares made by Miller Richard A Md , and a net purchase of 20,000 shares made by William Benton Jones .

In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 597,634 shares were bought by its insiders, resulting in a net purchase of 597,634 shares.

Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corvus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Bolt Biotherapeutics Inc do?

Who are the key executives at Bolt Biotherapeutics Inc?

Peter Moldt is the director of Bolt Biotherapeutics Inc. Other key executives at Bolt Biotherapeutics Inc include Chief Financial Officer William P. Quinn , 10 percent owner Vivo Capital Fund Viii, L.p. , and 10 percent owner Novo Holdings A/s .

Bolt Biotherapeutics Inc (BOLT) Insider Trades Summary

Over the past 18 months, Peter Moldt made no insider transaction in Bolt Biotherapeutics Inc (BOLT). Other recent insider transactions involving Bolt Biotherapeutics Inc (BOLT) include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .

In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc (BOLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc (BOLT) were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.

Bolt Biotherapeutics Inc (BOLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bolt Biotherapeutics Inc Insider Transactions

No Available Data

Peter Moldt Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Moldt. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Peter Moldt's mailing address is: Burlingame Ca 94010.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.